← All Categories

Remote Monitoring & Chronic Care

AI applied to remote patient monitoring and chronic disease management: monitoring vitals from connected devices, surfacing risk between visits, and coordinating clinical action for conditions such as hypertension, heart failure, diabetes, and COPD. Several vendors in this category pair software with an embedded clinical service or medical group; evaluation should distinguish the AI platform from the care delivery wrapper, examine autonomous resolution rates and escalation logic, and weigh published cost and outcome evidence over vendor testimonials.

Vendors in this category
7 indexed
Vendor Founded Headquarters Last Verified
E
Ellipsis Health
Voice AI care management for health plans and at risk providers, originating in vocal biomarker research for detecting depression and anxiety and now productized as Sage, an AI care manager. The distinguishing technical claim is the Empathy Engine, patented vocal biomarker technology trained on millions of live clinical patient calls, which reads emotional state from voice in real time rather than only transcribing words, and adapts tone and approach accordingly. Sage conducts inbound and outbound member calls covering health risk assessments, post discharge follow up, risk profiling, care gap closure, program enrollment, medication reminders, and triage, and is positioned explicitly as added staffing capacity rather than a chatbot, reserving clinicians for complex high touch interventions. Integrations include Salesforce Health Cloud and, through an April 2026 partnership with HealthEdge, the Care Solutions suite drawing on GuidingCare member data and returning outcomes to the platform. Company reported figures, which it acknowledges are not independently audited, include roughly 60 percent reduction in administrative tasks, 6x faster program enrollment, and 4x return on investment. Named customers per the company website include UnitedHealth Group, Aetna, Duke Health, and Highmark. Founded 2017 by CEO Mainul Mondal; approximately $75 million raised including a $45 million round in June 2025 co-led by Salesforce, Khosla Ventures, and CVS Health Ventures.
2017 San Francisco, California Jul 19, 2026
H
hellocare.ai
Inpatient virtual care platform, and the first vendor in this index covering AI assisted virtual nursing and virtual sitting inside the hospital rather than in the home. The platform is modular: AI Assisted Virtual Nursing supporting virtual rounding, admissions, and discharges; AI Assisted Virtual Sitting and Patient Safety Monitoring, where the AI models cover fall prevention, fall detection, and pressure injury prevention; plus ambient documentation, patient engagement, digital whiteboards and room signage, hospital at home, remote patient monitoring, and a digital clinic. Hardware is part of the offering, including smart carts and in wall fixed devices providing video in the patient room. The stated design intent is extending clinical capacity rather than replacing staff: continuous monitoring across multiple units simultaneously so a smaller number of nurses can observe more rooms and intervene earlier. Reported adoption grew from more than 70 US health systems in February 2026 to more than 100 by June 2026. Named enterprise deployments include Ardent Health (NYSE: ARDT) across more than 2,000 patient rooms, MultiCare Health System as its enterprise virtual care platform, and One Brooklyn Health. Headquartered in Clearwater, Florida.
Clearwater, Florida Jul 19, 2026
S
Sensi AI
Audio based AI monitoring for home care and senior living, and the third distinct sensing architecture in this lane. Small audio pods placed through a residence listen for verbal and non verbal cues rather than using cameras, a deliberate choice the founder attributes to cameras feeling intrusive in the home. The Care Agent continuously detects and predicts care events across physical, cognitive, and emotional wellbeing, and the company reports identifying more than 100 distinct insights, extending well past emergencies: alongside falls it flags possible urinary tract infections, pneumonia, early signs of cognitive decline, and softer signals including changes in activity level, sentiment, and lack of companionship. A clinical team including a social worker, occupational therapist, nurses, and geriatrics clinicians develops new data points on an ongoing basis. The platform has expanded beyond monitoring into agency operations with a Growth Agent handling inbound demand and an Ops Agent covering scheduling, callouts, and communication. The company reports serving 80 percent of the largest home care networks in North America and revenue tripling year over year for three consecutive years. Founded 2019 by Romi Gubes; $45 million Series C in October 2025 led by Qumra Capital brought total funding above $98 million.
2019 Austin, Texas Jul 19, 2026
D
Dimer Health
Clinician led transitional care focused on the high risk window after hospital discharge, sold to health systems and payors as a clinical service line rather than as software alone. The proprietary clinical AI, AiME, was built by clinicians and grounded in physician validated protocols: it engages patients in real time, interprets symptoms against the individual's medical history, medications, and comorbidities, continuously detects emerging risk signals, and escalates to a dedicated Transitionist, a licensed clinician who owns the episode of care from discharge through recovery. The model pairs an AI front door with a physician led practice, adding AI assisted care plans, documentation, and billing plus omnichannel round the clock patient support. The company is credited with large reductions in avoidable readmissions. As with several vendors in this category, buyers should evaluate the AI and the care delivery operation as two distinct things: what is being purchased is a staffed clinical service accelerated by AI, not a platform. Founded 2023; $13.5 million Series A in March 2026 led by Team8 and Table Management, bringing total funding to nearly $20 million.
2023 Florham Park, New Jersey Jul 8, 2026
S
Sword Health
AI care platform sold to self insured employers and health plans, indexed for those business to business products rather than the direct to consumer application launched in 2026, which is outside the scope of this record. Phoenix, the company's AI care specialist, delivers real time motion biofeedback and around the clock natural language support, paired with a licensed clinician who remains in the loop for every member: Doctors of Physical Therapy in the musculoskeletal programs, with specialist type varying by product. Thrive covers musculoskeletal care through digital physical therapy with a motion tracking device, and the line has extended into women's health (Bloom) and cardiometabolic care (Pulse, announced for later 2026 with outcomes based pricing and connected device integration). The company reports more than 800,000 members served, 11 million AI care sessions, over 1,000 clients including a fifth of the Fortune 500, and customer avoided costs exceeding $1 billion, alongside per member savings of $3,177 a year for the musculoskeletal program. Founded 2015 by Virgilio Bento; valued at $3 billion following a 2024 round led by Khosla Ventures and General Catalyst.
2015 Salt Lake City, Utah Jul 19, 2026
V
Verily
Precision health technology company, indexed here for its business to business products rather than its consumer app. Lightpath is an AI enabled chronic care management program sold to health plans, employers, and pharmacy benefit managers, using agents to triage and escalate members to a clinical team of physicians, pharmacists, and dietitians, with Lightpath Metabolic covering diabetes, prediabetes, and obesity. Workbench is a research data environment used by the NIH All of Us Research Program, the Michael J. Fox Foundation, and Helix. Sightline is a wastewater based epidemiology program for early infectious disease detection. The free Verily Me consumer application is outside the scope of this record. Formerly an Alphabet subsidiary; became an independent company in March 2026 alongside a $300 million investment round.
2015 South San Francisco, California Jul 19, 2026
C
Cadence
AI enabled chronic care management for older adults: supervised AI agents monitor daily vitals from connected devices, surface risk between visits, and coordinate clinical action for patients with hypertension, type 2 diabetes, heart failure, and COPD. Operates in partnership with more than 20 health systems with an embedded medical group, and reports 55 percent of vitals alerts resolved autonomously with a 3.5 minute median response time.
New York, New York Jul 12, 2026
AI Health Index

An independent reference for evaluating AI vendors in healthcare. No vendor pays for inclusion, placement, or rating.

Index Status
Last index update
July 19, 2026
The AI Health Index is an editorial reference, not a regulatory body. Vendor data is verified against published sources and public regulatory filings. Figures labeled “Estimated” have not been confirmed by the vendor. See the Methodology page for evaluation standards and limitations.
© 2026 AI Health Index
3801 N Capital of Texas Hwy, Ste E240 · Austin, TX 78746